Abstract #3500
Nootropics prevent the effect of scopolamine in an phMRI provocation model
Nikolett Hegeds 1 , Pl Kocsis 2 , Dvid Gajri 2 , Szabolcs Dvid 2 , Levente Deli 2 , Zsfia Pozsgay 2 , and Kroly Tihanyi 2
1
Gedeon Richter Plc., Budapest, Hungary,
2
Gedeon
Richter Plc., Hungary
The effective treatment of cognitive decline is still a
major challenge of the drug research. Scopolamine based
small animal phMRI provocation model can be a suitable
translational method for testing new compounds.
Scopolamine strongly decreased the BOLD responses in the
PFC but had no visible effect in other brain areas.
Scopolamines effect could be fully prevented with the
donepezil pretreatment, whereas vinpocetin and piracetam
caused a partial reversal of the BOLD responses only.
The new vinpocetin derivative RG compound exerted
partial effect also, but its effective dose was much
lower than that of the reference compound donepezil.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.